Mark L. Jacobson, Chief Operating Officer at Axsome Therapeutics, Inc. (AXSM), sold 61,346 shares at $103.45 ($6.4M) on 2025-05-28, disclosed to the SEC on 2025-05-28.
Scheduled sale ($6.4M) by Chief Operating Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $104.66 | 20,673 | $2.2M | 33.8% |
| 2 | $104.66 | 20,673 | $2.2M | 33.8% |
| 3 | $103.45 | 20,000 | $2.1M | 32.3% |
| Total | $104.27 avg | 61,346 | $6.4M | 100% |
| Filing → |
| AXSM | SELL | 2026-02-27 | $5.7M | — | Filing → |
| AXSM | SELL | 2025-09-22 | $1.2M | — | Filing → |
| AXSM | SELL | 2025-09-17 | $5.9M | — | Filing → |